QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=E090A53974DE6FBBC29DD4A64A82591C;jsessionid=5B1E3A2C8B6681B4C73F0A684453D921;jsessionid=55DFD0AFBCC57E8484E8329AC86E9574;jsessionid=83581A696E0B8FEE6915D190CC6B9FE5;jsessionid=0FB0B8546E95028F6840370771E10659 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=E090A53974DE6FBBC29DD4A64A82591C;jsessionid=5B1E3A2C8B6681B4C73F0A684453D921;jsessionid=55DFD0AFBCC57E8484E8329AC86E9574;jsessionid=83581A696E0B8FEE6915D190CC6B9FE5;jsessionid=0FB0B8546E95028F6840370771E10659